{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T07:40:29Z","timestamp":1775634029085,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1996,7,1]],"date-time":"1996-07-01T00:00:00Z","timestamp":836179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[1996,7]]},"DOI":"10.1007\/s002239900076","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T02:57:52Z","timestamp":1027565872000},"page":"6-11","source":"Crossref","is-referenced-by-count":80,"title":["Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis"],"prefix":"10.1007","volume":"59","author":[{"given":"M. C.","family":"Ellerington","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. C.","family":"Hillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. I. J.","family":"Whitcroft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. S.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Lees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. M.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. I.","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"591006_CR1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0140-6736(76)92217-0","volume":"i","author":"R Lindsay","year":"1976","unstructured":"Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC (1976) Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet i: 1038\u20131041","journal-title":"Lancet"},{"key":"591006_CR2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2362.1980.tb00033.x","volume":"10","author":"C Christiansen","year":"1980","unstructured":"Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund K, Transb0l IB (1980) Prevention of early postmenopausal bone loss: a controlled 2-year study in 315 normal females. Eur J Clin Invest 10:273\u2013279","journal-title":"Eur J Clin Invest"},{"key":"591006_CR3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF01622195","volume":"4","author":"TC Hillard","year":"1994","unstructured":"Hillard TC, Whitcroft SJ, Marsh MS, Ellerington MC, Lees B, Whitehead MI, Stevenson JC (1994) Long-term effects of transdermal and oral hormone replacement therapy on post-menopausal bone loss. Osteoporos Int 4:341\u2013348","journal-title":"Osteoporos Int"},{"key":"591006_CR4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0026-0495(84)90187-2","volume":"33","author":"HE Gruber","year":"1984","unstructured":"Gruber HE, Ivey JL, Baylink DJ, Matthews M, Nelp WB, Sisom K, Chesnut CH III (1984) Long-term calcitonin therapy in postmenopausal osteoporosis. Metabolism 33:295\u2013303","journal-title":"Metabolism"},{"key":"591006_CR5","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0140-6736(88)91712-6","volume":"i","author":"I MacIntyre","year":"1988","unstructured":"MacIntyre I, Stevenson JC, Whitehead MI, Wimalawansa SJ, Banks LM, Lealy MJR (1988) Calcitonin for prevention of postmenopausal bone loss. Lancet i:900\u2013902","journal-title":"Lancet"},{"key":"591006_CR6","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(87)92619-5","volume":"ii","author":"JY Reginster","year":"1987","unstructured":"Reginster JY, Denis D, Albert A, Deroisy R, Lecart MP, Fontaine MA, Lambelin P, Franchimont P (1987) 1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet ii: 1481\u20131483","journal-title":"Lancet"},{"key":"591006_CR7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2265.1989.tb00443.x","volume":"30","author":"K Overgaard","year":"1989","unstructured":"Overgaard K, Riis BJ, Christiansen C, Pdenphant J, Johansen JS (1989) Nasal calcitonin for treatment of established osteoporosis. Clin Endocrinol 30:435\u2013442","journal-title":"Clin Endocrinol"},{"key":"591006_CR8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00004728-198605000-00001","volume":"10","author":"LM Banks","year":"1986","unstructured":"Banks LM, Stevenson JC (1986) Modified method of spinal computed tomography for trabecular bone mineral measurements. J Comput Assist Tomogr 10:463\u2013467","journal-title":"J Comput Assist Tomogr"},{"key":"591006_CR9","first-page":"103","volume-title":"Osteoporosis. Proc Copenhagen Int Symp on Osteoporosis","author":"M Kleerekoper","year":"1984","unstructured":"Kleerekoper M, Parfitt AM, Elliss BI (1984) Measurement of vertebral fracture rate in osteoporosis. In: Christiansen C, Arnaud CD, Nordin BEC, Parfitt AM, Peck WA, Riggs BL (eds) Osteoporosis. Proc Copenhagen Int Symp on Osteoporosis, vol 1. Stiftsbogtrykkeri, Aalborg, pp 103\u2013109"},{"key":"591006_CR10","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/oxfordjournals.aje.a115204","volume":"129","author":"LJ III Melton","year":"1989","unstructured":"Melton LJ III, Kan SH, Frye MA, Wahmer HW, OFallon WM, Riggs BL (1989) Epidemiology of vertebral fractures in women. Am J Epidemiol 129:1000\u20131011","journal-title":"Am J Epidemiol"},{"key":"591006_CR11","first-page":"298","volume-title":"Pathophysiology and treatment of Paget\u2019s disease of bone","author":"JA Kanis","year":"1991","unstructured":"Kanis JA (1991) Pathophysiology and treatment of Paget\u2019s disease of bone. Martin Dunitz Ltd, London, p 298"},{"key":"591006_CR12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/09513599809029344","volume":"2","author":"JY Reginster","year":"1988","unstructured":"Reginster JY, Deroisy R, Denis D, Lecart MP, Sarlet N, Franchimont P (1988) Is there any place for salmon calcitonin in prevention of postmenopausal bone loss? Gynaecol Endocrinol 2:195\u2013204","journal-title":"Gynaecol Endocrinol"},{"key":"591006_CR13","first-page":"761","volume":"45","author":"G Rizzato","year":"1989","unstructured":"Rizzato G, Schiraldi G, Tosi G, Locicero S, Montemurro L, Zanni D, Sisti S (1989) Administration of salmon calcitonin nasal spray for long-term treatment of corticosteroid-induced osteoporosis. A preliminary report. Curr Ther Res 45:761\u2013766","journal-title":"Curr Ther Res"},{"key":"591006_CR14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/bmj.305.6853.556","volume":"305","author":"K Overgaard","year":"1992","unstructured":"Overgaard K, Hansen MA, Jensen SB, Christiansen C (1992) Effect of calcitonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. Br Med J 305:556\u2013561","journal-title":"Br Med J"},{"key":"591006_CR15","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/bmj.305.6862.1124","volume":"305","author":"JA Kanis","year":"1992","unstructured":"Kanis JA, Johnell O, Gullberg B, Allander E, Dilsen G, Gennari C, Vas AAL, Lyritis GP, Mazzuoli G, Miravet L, Passeri M, Cano RP, Rapado A, Ribot C (1992) Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. Br Med J 305:1124\u20131128","journal-title":"Br Med J"},{"key":"591006_CR16","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","volume":"322","author":"T Storm","year":"1990","unstructured":"Storm T, Thamsborg G, Steiniche T, Genant HK, Srensen OH (1990) Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 322:1265\u20131271","journal-title":"N Engl J Med"},{"key":"591006_CR17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9343(93)90350-X","volume":"95","author":"ST Harris","year":"1993","unstructured":"Harris ST, Watts NB, Jackson RD, Genant HK, Wasnich RD, Ross P, Miller PD, Licata AA, Chesnut CH III (1993) Four-year study of intermittent cyclic etidronate treatment of post-menopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med 95:557\u2013567","journal-title":"Am J Med"},{"key":"591006_CR18","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","volume":"333","author":"UA Liberman","year":"1995","unstructured":"Liberman UA, Weiss SR, Broil J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downes RW, Dequeker J, Favus M, Seeman E, Recker RR, Capizzi T, Santora AC, Lombardi A, Shah RV, Hirsch LJ, Karpf DB (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437\u20131443","journal-title":"N Engl J Med"},{"key":"591006_CR19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(84)92272-4","volume":"i","author":"BF Boyce","year":"1984","unstructured":"Boyce BF, Smith L, Fogelman I, Johnston E, Ralston S, Boyle IT (1984) Focal osteomalacia due to low-dose diphosphonate therapy in Paget\u2019s disease. Lancet i:821\u2013824","journal-title":"Lancet"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s002239900076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s002239900076\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s002239900076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T07:41:20Z","timestamp":1558683680000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s002239900076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,7]]}},"alternative-id":["591006"],"URL":"https:\/\/doi.org\/10.1007\/s002239900076","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,7]]}}}